Pioneering the Future of Human Longevity

We're not just treating aging—we're reversing it

Celljevity began with a simple question: What if we could teach old cells to be young again? Today, we're the first company to successfully integrate cellular rejuvenation technology with premium clinical care and AI-powered health optimization.

Our Foundation

The principles that guide our mission to make longevity accessible to all

Vision • Mission • Promise

Vision

A world where aging is a choice, not an inevitability

Mission

To reverse biological aging through safe, proven cellular rejuvenation technology

Promise

Evidence-based treatments with uncompromising safety standards

Core Values

Scientific Integrity

Every claim backed by data

Patient Safety

Zero compromise on safety protocols

Innovation

Continuously advancing the science

Accessibility

Working to democratize longevity

Transparency

Open about our methods and results

Join Our Mission

Whether you're a patient, healthcare provider, researcher, or investor, we invite you to be part of the longevity revolution.

Our team

Our multidisciplinary team spans executive leadership, scientific research, medical advisory, and strategic guidance — united in revolutionizing human longevity through cutting-edge cellular therapies.

Executive Leadership & Core Team

Our core leadership team driving Celljevity's mission forward with decades of combined experience in biotechnology, medicine, and business innovation.

  • Diederik van der Reijt, Chief Executive Officer

    Diederik van der Reijt

    Chief Executive Officer

    Visionary leader driving Celljevity's mission to revolutionize cellular regeneration and human longevity.

  • Dr. Digvijay Gahtory, Chief Business Officer

    Dr. Digvijay Gahtory

    Chief Business Officer

    Strategic business leader focused on scaling Celljevity's global operations and partnerships.

  • Dr. Henk Viëtor, Chief Medical Officer

    Dr. Henk Viëtor

    Chief Medical Officer

    Distinguished physician and researcher specializing in clinical immunology, transfusion medicine, and clinical genetics. Graduate of University of Amsterdam with extensive experience in biotechnology entrepreneurship and co-founder of 15+ biotech companies.

  • Dr. Christopher Juel-Jensen, Chief Integration Officer

    Dr. Christopher Juel-Jensen

    Chief Integration Officer

    Integration leader ensuring seamless coordination across Celljevity's global operations and technology platforms.

  • David Maman, Chief Operational Officer

    David Maman

    Chief Operational Officer

    Operations expert ensuring seamless delivery of Celljevity's cutting-edge cellular therapies worldwide.

  • Dan Fobes, Chief Technology Officer

    Dan Fobes

    Chief Technology Officer

    Technology innovator building the digital infrastructure powering Celljevity's AI-driven health platform.

  • Karen Brink, Chief Growth Officer

    Karen Brink

    Chief Growth Officer

    Growth strategist expanding Celljevity's reach and impact in the global longevity market.

  • Daniel Erasmus, Chief Artificial Intelligence Architect

    Daniel Erasmus

    Chief Artificial Intelligence Architect

    CEO of Erasmus.AI and creator of domain-specific AI models such as ClimateGPT. Member of OECD's AI Expert Group and Club of Rome with over 25 years of experience in global strategy and foresight advisory.

Additional Leadership & Core Team

Supporting our mission with specialized expertise across operations, finance, and regional leadership.

Rhys Tombling

Finance Director

Financial leader managing Celljevity's strategic investments and sustainable growth initiatives.

Furqan Athar

President MENA Operations

Regional leader expanding Celljevity's presence across the Middle East and North Africa.

Alexander Berg

Life Sciences Director

Life sciences expert advancing Celljevity's research and development initiatives.

Ismael Mrani Alaoui

President Morocco Operations

Regional operations leader expanding Celljevity's presence in North Africa.

Kieran Hothi

Technology Director

Technology director driving innovation in Celljevity's digital health solutions.

Henri-Nicolas Olivier

President EU Operations

Regional operations leader expanding Celljevity's presence across Europe.

Advisory Boards

Distinguished experts and thought leaders providing strategic guidance and clinical expertise to advance our mission.

Dr. Yi Eve Sun

Professor, Tonji University

Renowned professor contributing expertise in regenerative medicine research.

Dr. Lin Quan

Clinical Director, UCLA

UCLA Clinical Director contributing research expertise in cellular medicine.

Dr. Adeel Khan

Board-Certified Physician

Board-certified physician providing clinical expertise in regenerative therapies.

Dr. Henry Delmar

Founder, Clinic Del Mar

Founder of Clinic Del Mar, pioneering advanced medical treatments and patient care.

Dr. Pierre Maldiney

Cardiologist & Anti-Aging Physician

Specialized cardiologist and anti-aging physician advancing longevity medicine.

Dr. Murat Bozkurt

Medical Advisor

Professor of Orthopedics and Traumatology with over 25 years of experience in joint replacement surgery and sports medicine. Fellow at Hospital for Special Surgery (New York) and member of the American Academy of Orthopedic Surgeons.

Dr. h.c. Nina Storms

Strategic Advisor

Strategic advisor specializing in healthcare innovation and market development.

Neil Bush

Senior Advisor

Senior advisor contributing strategic insights for Celljevity's growth initiatives.

Stephen Bradley

Non-Executive Director

Non-executive director providing independent oversight and strategic guidance.

Paul Spiegel

Strategic Advisor

Strategic advisor providing guidance on global market expansion and business development.

Anne Popkin

Strategic Advisor

Strategic advisor providing guidance on business development and strategic initiatives.

Jörg Rieker

Strategic Advisor

Strategic advisor providing expertise in European healthcare markets and operations.

Dave Bizer

Investment Advisor

Co-founder of GCW Global Customised Wealth specializing in private equity and family office investments. Brings deep healthcare investment expertise to the team.

Jamie Grooms

Executive Board Member

Executive board member contributing strategic leadership and governance expertise.

Medical Disclaimer: Celljevity's Prometheus technology is currently investigational and not approved by the FDA. Treatment availability varies by jurisdiction. Individual results may vary. Please consult with your healthcare provider. The statements on this website have not been evaluated by the Food and Drug Administration. Our treatments are not intended to diagnose, treat, cure, or prevent any disease.